Why the study?
Does the amount, type, and location of advanced glycation end-products differ between patients with AAA or PAD with and without diabetes mellitus?
Does the amount, type, and location of advanced glycation end-products differ between patients with AAA or PAD with and without diabetes mellitus?
The ARTERY study protocol outlines a cross-sectional approach to investigate whether advanced glycation end-products explain the diverging effects of diabetes mellitus on peripheral artery disease and abdominal aortic aneurysm.
Answers are grounded in this paper and cite their sources.
This protocol establishes a framework to explore the paradoxical vascular effects of diabetes; leaves open whether.
Introduction Diabetes mellitus is a well-defined risk factor for peripheral artery disease (PAD), but protects against the development and growth of abdominal aortic aneurysm (AAA). Diabetes mellitus is associated with arterial stiffening and peripheral arterial media sclerosis. Advanced glycation end-products (AGEs) are increased in diabetes mellitus and cardiovascular disease. AGEs are known to form cross-links between proteins and are associated with arterial stiffness. Whether AGEs contribute to the protective effects of diabetes mellitus in AAA is unknown. Therefore, the ARTERY ( A dvanced glycation end-p R oducts in patients with peripheral ar T ery dis E ase and abdominal ao R tic aneur Y sm) study is designed to evaluate the role of AGEs in the diverging effects of diabetes mellitus on AAA and PAD. Methods and analysis This cross-sectional multicentre study will compare the amount, type and location of AGEs in the arterial wall in a total of 120 patients with AAA or PAD with and without diabetes mellitus (n=30 per subgroup). Also, local and systemic vascular parameters, including pulse wave velocity, will be measured to evaluate the association between arterial stiffness and AGEs. Finally, AGEs will be measured in serum, urine, and assessed in skin with skin autofluorescence using the AGE Reader. Ethics and dissemination This study is approved by the Medical Ethics committees of University Medical Center Groningen, Martini Hospital and Medisch Spectrum Twente, the Netherlands. Study results will be disseminated through peer-reviewed journals and scientific events. Trial registration number trialregister.nl NTR 5363.
No takes yet. Share an insight, caveat, or question.
Vos et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: